Trial intelligence / Profile preview

Etanercept in Kawasaki Disease

NCT00841789Phase 2Completed

Start
Mar 2009
Primary completion
Jan 2018
Modality
Fc-Fusion Proteins
Countries
2
01

Overview

A Phase 2 trial of etanercept in Kawasaki disease (KD). Started Mar 2009; status: completed.

02

Drugs

etanercept
03

Conditions

Kawasaki disease (KD)

Beyond the preview

Go deeper on NCT00841789.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00841789.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call